𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of antibody responses against a neutralizing epitope on the glycoprotein E2 of classical swine fever virus

✍ Scribed by Y. Qi; L. C. Liu; B. Q. Zhang; Z. Shen; J. Wang; Y. H. Chen

Publisher
Springer Vienna
Year
2008
Tongue
English
Weight
321 KB
Volume
153
Category
Article
ISSN
1432-8798

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Peptide vaccine candidates against class
Peptide vaccine candidates against classical swine fever virus: T cell and neutralizing antibody responses of dendrimers displaying E2 and NS2–3 epitopes
✍ Marta MonsΓ³; Joan Tarradas; Beatriz G. de la Torre; Francisco Sobrino; Llilianne πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 361 KB

## Abstract Three peptide‐based systems integrating B and T antigenic sites of CSFV and displaying the B epitopes in fourfold presentation have been designed and produced, and shown to bring about significant enhancements in immunogenicity over the peptides in monomeric form. Of the different strat

Characterization of the hepatitis C viru
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
✍ Alexander W. Tarr; Ania M. Owsianka; Judith M. Timms; C. Patrick McClure; Richar πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 680 KB

The mouse monoclonal antibody (MAb) AP33, recognizing a 12 amino acid linear epitope in the hepatitis C virus (HCV) E2 glycoprotein, potently neutralizes retroviral pseudoparticles (HCVpp) carrying genetically diverse HCV envelope glycoproteins. Consequently, this antibody and its epitope are highly

A point mutation at Asn-534 that disrupt
A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization
✍ Mikiko Sasayama; Ikuo Shoji; Myrna Adianti; Da-Peng Jiang; Lin Deng; Takafumi Sa πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 154 KB

## Abstract The molecular basis of antibody neutralization against hepatitis C virus (HCV) is poorly understood. The E2 glycoprotein of HCV is critically involved in viral infectivity through specific binding to the principal virus receptor component CD81, and is targeted by anti‐HCV neutralizing a